AHR and breast carcinoma: The inclusion of breast cancer samples was also based on a recent report from Eltom et al (2006), that the levels of nuclear AHR – the cytoplasmic interaction partner of AIP – were dramatically elevated in human breast carcinomas of advanced malignancy compared to earlier stages of tumour progression.